Cite
HARVARD Citation
Hopkins, P. et al. (n.d.). 352Pharmacokinetics and pharmacodynamics of alirocumab in patients with autosomal dominant hypercholesterolemia associated with PCSK9 gain-of-function or ApoB loss-of-function mutations. European heart journal. p. . [Online].